UK markets close in 1 hour 48 minutes

ARCT Jun 2024 17.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
As of 12:29PM EDT. Market open.
Full screen
Previous close1.0000
Open0.7000
Bid0.3000
Ask1.0000
Strike17.50
Expiry date2024-06-21
Day's range0.7000 - 1.8600
Contract rangeN/A
Volume8
Open interest4
  • Business Wire

    Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors

    SAN DIEGO, June 20, 2024--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, today announced the appointment of a new independent director, Moncef Slaoui, Ph.D., to the Company's Board of Directors.

  • GuruFocus.com

    Insider Sale: CFO Andy Sassine Sells 50,000 Shares of Arcturus Therapeutics Holdings Inc (ARCT)

    On June 12, 2024, Andy Sassine, the Chief Financial Officer of Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), executed a significant transaction by selling 50,000 shares of the company.

  • Business Wire

    Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference

    SAN DIEGO, June 07, 2024--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, today presented Phase 1 results in healthy volunteers and Phase 1b interim data in people with CF for ARCT-032, an inhaled investigational mRNA therapeutic, at the 47th European Cystic Fibrosis Conference in G